Resourcen
- Leitlinien der Neurologie
- Enzensberger W, von Giesen HJ: Antiretroviral therapy from a neurological point of view. German Neuro-AIDS study group (DNAA). Eur J Med Res 4: 456-62, 1999 -8000
- Schielke E und die DNAA: Erkrankungen des peripheren Nervensystems und der Muskulatur bei der HIV-Infektion. Nervenarzt 71: 442-450, 2000
- Eggers C und die DNAA: HIV-1-assoziierte Encephalopathie und Myelopathie. Nervenarzt 71: 677-684, 2000.
- Eggers C and the DNAA: HIV-1 associated encephalopathy and myelopathy. J Neurol: 249: 1132-1136, 2002
- Rosenkranz T und die DNAA: Aktuelle Diagnostik und Therapie opportunistischer Hirnerkrankungen bei AIDS. Dtsch Med Wochenschr 127: 1479-1485, 2002
- Hahn K, Arendt G, Braun JS, von Giesen HJ, Husstedt IW, Maschke M, Schielke E for the German Neuro-AIDS working group: A placebo-controlled trial of Gabapentin for painful HIV-associated sensory neuropathies. J Neurol 251: 1260-1266, 2004
- Hahn K, Maschke M, Eggers C, Husstedt IW, Arendt G. Update HIV and neurology.
Dtsch Med Wochenschr. 2016 ;141:51-57 - Merins V, Hahn K. Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid.Eur J Med Res.2015; 20:81
- Rosenkranz T, Novas M, Terborg C. PML in a patient with lymphocytopenia treated with dimethyl fumarate. N Engl J Med. 2015; 372:1476-147.
- Grauer OM, Reichelt D, Grüneberg U, Lohmann H, Schneider-Hohendorf T, Schulte-Mecklenbeck A, Gross CC, Meuth SG, Wiendl H, Husstedt IW. Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. Ann Clin Transl Neurol. 2015;906-919
- Raber JM, Reichelt D, Grüneberg-Oelker U, Philipp K, Stubbe-Dräger B, Husstedt IW. Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain. Acta Neurol Belg. 2015;115:335-343
- Arendt G, Grauer O, Hahn M, Masckke M, Obermann M, Husstedt IW. Neues bei HIV und Neuro-Aids. Akt Neurol 2015; 42:445-455
- Hinsch MC, Reichelt D, Husstedt IW. Acute psychosis as a side effect of efavirenz therapy with metabolic anomalies: an important differential diagnosis of HIV-associated psychoses.
Nervenarzt. 2014. 85; 1304-1308. - Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, Oelker-Grueneberg U, Schwindt W, Dziewas R, Husstedt IW. Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci. 2015;125:601-611.
- Koedel U, Fingerle V, Pfister HW. Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol. 2015;11:446-456
- Eggers C für die Deutsche Neuro-AIDS-Arbeitsgemeinschaft (DNAA). HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management. Nervenarzt. 2014; 85:1280-1290
- Lummel N, Koch M, Klein M, Pfister HW, Brückmann H, Linn J. Spectrum and Prevalence of Pathological Intracranial Magnetic Resonance Imaging Findings in Acute Bacterial Meningitis.Clin Neuroradiol. 2014 Sep 23. [Epub ahead of print]
- Schneider-Hohendorf T, Philipp K, Husstedt IW, Wiendl H, Schwab N.
Specific loss of cellular L-selectin on CD4(+) T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection.AIDS. 2014; 28:793-795. - Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014 Nov;23:1192-1204.
- Horn A, Scheller C, du Plessis S, Arendt G, Nolting T, Joska J, Sopper S, Maschke M, Obermann M, Husstedt IW, Hain J, Maponga T, Riederer P, Koutsilieri E; German Competence Network HIV/AIDS.Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.
J Neural Transm (Vienna). 2013 Oct;120(10):1411-9. doi: 10.1007/s00702-013-1086-x. Epub 2013 Sep 6. - Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.
Mind Exchange Working Group.
Clin Infect Dis. 2013 Apr;56(7):1004-17 - Hahn K, Schildmann EK, Baumeister C, Seggern Iv, Schielke E.
Int J Neurosci. 2012 Nov;122(11):630-6
Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.